Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FKSW9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,365
Award facts
- Contract value 100% obligated
- $16,365.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,365.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Dupixent is a biologic medication used to treat atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, making this delivery consistent with AmerisourceBergen's extensive portfolio of specialty pharmaceutical products supplied through the DLA's global medical supply chain. The company's federal contract awards demonstrate a strong capability to meet military healthcare requirements through competitive procurement processes, with contract values ranging from small transactions to orders exceeding $45,000.
Quick answers
Who was awarded contract SPE2DB26FKSW9?
SPE2DB26FKSW9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FKSW9 worth?
The government has obligated $16,365 on SPE2DB26FKSW9.
Is contract SPE2DB26FKSW9 an order under another contract?
Yes. SPE2DB26FKSW9 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB26FKSW9 competed?
The extent of competition for SPE2DB26FKSW9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award